MedPath
HSA Approval

MINIMS TETRACAINE HYDROCHLORIDE EYE DROPS 0.5% w/v

SIN04188P

MINIMS TETRACAINE HYDROCHLORIDE EYE DROPS 0.5% w/v

MINIMS TETRACAINE HYDROCHLORIDE EYE DROPS 0.5% w/v

April 14, 1990

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Regulatory Information

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

SOLUTION

**4.2 Posology and Method of Administration** Adults and children One drop or as required. Each Minims unit should be discarded after use.

OPHTHALMIC

Medical Information

**4.1 Therapeutic Indications** Ocular anaesthetic for topical instillation into the conjunctival sac.

**4.3 Contraindications** Not to be used in patients with a known hypersensitivity to the product. Tetracaine is hydrolysed in the body to p-amino-benzoic acid and should not therefore be used in patients being treated with sulphonamides. In view of the immaturity of the enzyme system which metabolises the ester type local anaesthetics in premature babies, tetracaine should be avoided in these patients.

S01HA03

tetracaine

Manufacturer Information

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

LABORATOIRE CHAUVIN SA

Active Ingredients

TETRACAINE HYDROCHLORIDE

0.005g/mL

Tetracaine

Documents

Package Inserts

Minims Tetracaine Eyedrops PI.pdf

Approved: July 29, 2010

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MINIMS TETRACAINE HYDROCHLORIDE EYE DROPS 0.5% w/v - HSA Approval | MedPath